Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis
Derrick D Eichele, Kusum K Kharbanda, Department of Internal Medicine, Nebraska Medical Center, Omaha, NE 68198, United States
Kusum K Kharbanda, Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE 68105, United States
Kusum K Kharbanda, Department of Biochemistry and Molecular Biology, Nebraska Medical Center, Omaha, NE 68198, United States
Author contributions: Both authors equally contributed to this paper with conception, literature review, drafting and critical revision, editing, and approval of the final version.
Supported by the Department of Veterans Affairs, Office of Research and Development (Biomedical Laboratory Research and Development), No. BX001155.
Conflict-of-interest statement: No potential conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kusum K Kharbanda, PhD, Professor, Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service (151), 4101 Woolworth Avenue, Omaha, NE 68105, United States. firstname.lastname@example.org
Telephone: +1-402-9953752 Fax: +1-402-4490604
Received: May 11, 2017
Peer-review started: May 12, 2017
First decision: June 5, 2017
Revised: July 7, 2017
Accepted: August 1, 2017
Article in press: August 2, 2017
Published online: September 7, 2017